This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

9 Ex-Dividend Stocks With Buy Ratings

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Carnival

The cruise company is doing an audit on all of its cruise lines' safety measures following the Costa Concordia crash in January.

"We continue to believe that the adverse effects on demand caused by the Costa Concordia incident will be relatively short lived and that investors should focus on the medium term strengths of the business," Jefferies analysts wrote in a Feb. 7 report. "Capacity additions remain subdued and underlying demand is firm, buoyed by decent US GDP growth and falling unemployment in key markets such as the US and Germany."

Forward Annual Dividend Yield: 3.3%

Rated "B- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin dropped from the previous year.

Carnival has very weak liquidity. Its Quick Ratio is 0.12, which demonstrates a lack of ability to meet its short-term cash needs.

In the fourth quarter, stockholders' net worth has increased 3.47% from the prior year.

TheStreet Ratings' price target is $36.93. The stock closed Friday at $30.97 and has declined 5.12% year to date.






Allergan

The health care company reported earlier this month earnings of $279.8 million, or 92 cents a share, up from year-ago earnings of $263.1 million, or 87 cents.

"Management sounded confident in the potential for its current products and pipeline to drive strong growth," Bank of America Merrill Lynch analysts wrote in a Feb. 9 report. "Re-loading the pipeline through both internal and external efforts (supported by strong cash flow) will be a priority for 2012. We are maintaining our Buy rating, as we believe that AGN's diversified revenue base, strong pipeline, focus on innovation, and productive R&D engine position the company well for continued strong and sustainable revenue and EPS growth."

Forward Annual Dividend Yield: 0.2%

Rated "A- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was basically the same as the prior year.

Allergan is extremely liquid. Its Quick Ratio is 3.47, which shows the company can meet its short-term cash needs.

In the fourth quarter, stockholders' net worth increased 11.60% from the prior year.

TheStreet Ratings' price target is $109.39. The stock closed Friday at $87.91 and has risen slightly year to date.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

2 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
LTD $0.00 0.00%
CCL $47.10 -1.50%
HSY $100.33 -0.57%
NUS $58.82 -2.30%
RHI $59.24 -2.10%

Markets

DOW 17,674.09 -102.03 -0.57%
S&P 500 2,054.64 -13.25 -0.64%
NASDAQ 4,860.6690 -40.2160 -0.82%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs